Gelaphar SRL
1.9 FTEGelaphar reported total assets of 774,089 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026), with 1.9 full-time equivalent.
The score of Gelaphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +72 % Total assets +18 % Headcount (avg FTE) +19 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Gelaphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 65,242 € | ||||
| Equity | 437,163 € | ||||
| Cash | 210,146 € | ||||
| EBITDA | 129,103 € | ||||
| Total assets | 774,089 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 17 Jul 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
Gelaphar's financial analysis
- Solvency56.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Gelaphar
Gelaphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0426.709.631
- VAT number
- BE0426709631
- Peppol
- Registered · 0208:0426709631 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Jan 1985
- Registered office
- 3798 Voeren
- Size
- Micro · 1.9 FTE
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Gelaphar (SRL) has been based in Voeren since 1985, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 65,242 € and equity of 437,163 €; its revenue is not published. With 1.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 56.5%, above the median of its sector (44.2%).
Companies similar to Gelaphar
Companies in the same business, of comparable size and area, outside its group.
- Amygephar Retail sale of pharmaceutical products Neupré · balance sheet 717,127 €
- Devillé - Boeykens Retail sale of pharmaceutical products Londerzeel · balance sheet 631,150 €
- AG Phar Retail sale of pharmaceutical products Liège · balance sheet 638,057 €
- KG Farma Retail sale of pharmaceutical products Leuven · balance sheet 622,811 €
- Apotheek Hoevenaeghel Retail sale of pharmaceutical products Huldenberg · balance sheet 725,002 €
- Pharmacie Conscience Retail sale of pharmaceutical products Evere · balance sheet 998,868 €
- Benepharma Retail sale of pharmaceutical products Overijse · balance sheet 813,930 €
- J&L Pharma Retail sale of pharmaceutical products Antwerp · balance sheet 664,453 €
Frequently asked questions about Gelaphar
What is the revenue of Gelaphar?
Gelaphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Gelaphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0426709631 for Gelaphar, if the company is VAT-registered. Its company number (CBE) is 0426.709.631.
Where is the registered office of Gelaphar?
According to the CBE register, the registered office of Gelaphar is in 3798 Voeren.
What is the equity of Gelaphar?
At the close of the 2025 financial year, the equity of Gelaphar amounts to 437,163 €, a solvency of 56.5% of total assets.
How many people work at Gelaphar?
1.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Gelaphar?
The register lists 2 active mandates at Gelaphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Gelaphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →